While it shows potential for promoting tissue repair and reducing inflammation, its premature to label it a cure for chronic conditions without more robust clinical data
More significantly, MOTS-c administration shifted the trajectory of age-related metabolic decline, indicating that the peptide's benefits are not limited to preventing dysfunction in young animals but can partially reverse established decline [2]
Research interest may include cellular signalling, extracellular matrix research, oxidative stress models, collagen-associated pathway research and broader peptide comparison studies
But the reconstituted peptides need to be placed in the fridge and used as soon as possible
This conservative starting point allows assessment of individual response before increasing
Presented for research literature review only Pcsi I et al